Ke Shi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ke Shi has a total of 68 co-authors. Here are the top co-authors by number of shared publications:
- Zhi-Gang Yang
Department of Radiology, West China Hospital, Sichuan University, Chengdu, China
12 shared publications - Ying-Kun Guo
Department of Radiology, Key Laboratory of Obstetric & Gynecologic and Pediatric Diseases and Birth Defects of Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, China
10 shared publications - Huayan Xu
Department of Radiology, West China Second University Hospital, Sichuan University, Chengdu, China
5 shared publications - Yuan Li
Department of Radiology West China Hospital, Sichuan University Chengdu Sichuan China
5 shared publications - Wei-Feng Yan
Department of Radiology, West China Hospital, Sichuan University, Chengdu, China
4 shared publications - Kai-Yue Diao
Department of Radiology, West China Hospital, Sichuan University, 37# Guo Xue Xiang, Chengdu, Sichuan, 610041, China
3 shared publications
Latest Publications
- Open Access
- 9 April 2026
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 25 (1)
Diabetes-related differences in body composition and their prognostic value among patients with heart failure and preserved ejection fraction: a cardiac-MRI-based study
Heart failure and diabetes mellitus share common risk factors and can independently regulate the body composition profile of patients. Approximately one-third of patients with heart failure and preserved ejection fraction (HFpEF) have concomitant diabetes mellitus, but the additional impact of diabetes on the body composition of HFpEF patients and its associations with prognosis have not been explored. This study included 281 HFpEF patients, among whom 87 had type 2 diabetes (T2DM). On the basis of their cardiac magnetic resonance (MR) images, regional adipose tissue (including subcutaneous, visceral and paracardial adipose tissue) as well as thoracic skeletal muscle were measured and compared between the diabetic and non-diabetic groups. Clinical endpoints were recorded and the predictive performance of body composition parameters and body mass index (BMI) for adverse events was assessed using multivariable Cox regression analysis in the overall HFpEF population and subgroups stratified by diabetes. HFpEF patients with concomitant diabetes were significantly older (65.06 ± 12.92 vs. 57.98 ± 14.44 years, p < 0.001). The LVEDV index and LVSV index were significantly lower in the T2DM group. The paracardial adipose tissue (ParaAT index) was noticeably greater in the T2DM group than in the non-T2DM group (76.21 vs. 65.60 ml/m2, p = 0.005). In the overall HFpEF population, the increase in the skeletal muscle index (SMI) corresponded to a linear decrease of prognostic risks. In contrast, the increase in the ParaAT-VAT ratio and ParaAT-muscle ratio corresponded to linearly increasing risks of poor outcomes. BMI demonstrated a non-linear correlation with survival risks (p for nonlinearity: 0.031) and the lowest tertile compared with the middle tertile increased survival risks significantly. Subgroup analysis revealed that the prognostic risks associated with the ParaAT-VAT ratio and ParaAT-muscle ratio were greater in diabetic HFpEF patients (adjusted HR: 1.069 [1.022, 1.117] and 1.948 [1.391, 2.729], respectively) than in nondiabetic patients (adjusted HR: 1.053 [1.006-1.103] and 1.597 [1.018, 2.505], respectively). Protective role from increased SMI persisted among the non-T2DM patients (adjusted HR: 0.968 [0.951, 0.985], p < 0.001) but not among the T2DM patients (adjusted HR: 0.990 [0.968, 1.012], p = 0.380). The lowest tertile group of BMI for non-T2DM patients or instead, the highest tertile group of BMI for T2DM patients led to an unfavorable prognosis. Concomitant diabetes exacerbated paracardial adipose excess among HFpEF patients and worsened the association between body composition and adverse outcomes.
- 9 April 2026
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 25 (1)
Open AccessDiabetes-related differences in body composition and their prognostic value among patients with heart failure and preserved ejection fraction: a cardiac-MRI-based study
Heart failure and diabetes mellitus share common risk factors and can independently regulate the body composition profile of patients. Approximately one-third of patients with heart failure and preserved ejection fraction (HFpEF) have concomitant diabetes mellitus, but the additional impact of diabetes on the body composition of HFpEF patients and its associations with prognosis have not been explored. This study included 281 HFpEF patients, among whom 87 had type 2 diabetes (T2DM). On the basis of their cardiac magnetic resonance (MR) images, regional adipose tissue (including subcutaneous, visceral and paracardial adipose tissue) as well as thoracic skeletal muscle were measured and compared between the diabetic and non-diabetic groups. Clinical endpoints were recorded and the predictive performance of body composition parameters and body mass index (BMI) for adverse events was assessed using multivariable Cox regression analysis in the overall HFpEF population and subgroups stratified by diabetes. HFpEF patients with concomitant diabetes were significantly older (65.06 ± 12.92 vs. 57.98 ± 14.44 years, p < 0.001). The LVEDV index and LVSV index were significantly lower in the T2DM group. The paracardial adipose tissue (ParaAT index) was noticeably greater in the T2DM group than in the non-T2DM group (76.21 vs. 65.60 ml/m2, p = 0.005). In the overall HFpEF population, the increase in the skeletal muscle index (SMI) corresponded to a linear decrease of prognostic risks. In contrast, the increase in the ParaAT-VAT ratio and ParaAT-muscle ratio corresponded to linearly increasing risks of poor outcomes. BMI demonstrated a non-linear correlation with survival risks (p for nonlinearity: 0.031) and the lowest tertile compared with the middle tertile increased survival risks significantly. Subgroup analysis revealed that the prognostic risks associated with the ParaAT-VAT ratio and ParaAT-muscle ratio were greater in diabetic HFpEF patients (adjusted HR: 1.069 [1.022, 1.117] and 1.948 [1.391, 2.729], respectively) than in nondiabetic patients (adjusted HR: 1.053 [1.006-1.103] and 1.597 [1.018, 2.505], respectively). Protective role from increased SMI persisted among the non-T2DM patients (adjusted HR: 0.968 [0.951, 0.985], p < 0.001) but not among the T2DM patients (adjusted HR: 0.990 [0.968, 1.012], p = 0.380). The lowest tertile group of BMI for non-T2DM patients or instead, the highest tertile group of BMI for T2DM patients led to an unfavorable prognosis. Concomitant diabetes exacerbated paracardial adipose excess among HFpEF patients and worsened the association between body composition and adverse outcomes.
- 1 February 2026
- Published by Radiological Society of North America (RSNA) in Radiology: Cardiothoracic Imaging
- Vol. 8 (1) , e250268
Additive Effects of Diabetes on Myocardial Perfusion and Fibrosis in Hypertrophic Cardiomyopathy Assessed with Cardiac MRI
In patients with hypertrophic cardiomyopathy, concomitant diabetes was associated with impaired myocardial perfusion and more frequent subendocardial late gadolinium enhancement at cardiac MRI.
- 1 February 2026
- Published by Radiological Society of North America (RSNA) in Radiology: Cardiothoracic Imaging
- Vol. 8 (1) , e250268
Additive Effects of Diabetes on Myocardial Perfusion and Fibrosis in Hypertrophic Cardiomyopathy Assessed with Cardiac MRI
In patients with hypertrophic cardiomyopathy, concomitant diabetes was associated with impaired myocardial perfusion and more frequent subendocardial late gadolinium enhancement at cardiac MRI.
- Open Access
- 1 January 2026
- Published by AME Publishing Company in Quantitative Imaging in Medicine and Surgery
- Vol. 16 (1) , 49
Clinical and cardiac magnetic resonance imaging features for differentiation between acute myocardial infarction with and without obstructive coronary arteries
Misdiagnosis often occurs in patients with myocardial infarction (MI) with nonobstructive coronary arteries (MINOCA) and MI with obstructive coronary arteries (MIOCA). This study explored the clinical and imaging characteristics of patients with MINOCA and MIOCA. Patients with acute MI (AMI) who underwent cardiac magnetic resonance (CMR) imaging and coronary angiography (CAG) were evaluated. According to coronary stenosis degree (>50%), patients with AMI (n=147) were divided into the MINOCA and MIOCA groups. The cardiac function and CMR characteristics of the two subgroups were emphasized in analysis. The MINOCA group had a lower proportion of patients with hypertension (29.4% vs. 55.2%), hyperlipoproteinemia (9.8% vs. 16.7%), diabetes (19.6% vs. 37.5%), wall motion abnormalities (39.3% vs. 75%), complex (both epicardial and subendocardial infarction) infarct type (19.6% vs. 29.2%), and multiple infarct territories (58.8% vs. 77.1%) than did the MIOCA group. Compared with the MIOCA group, the MINOCA group had a smaller left ventricular (LV) infarct size and a lower infarct size rate. The MINOCA group had a higher LV ejection fraction (LVEF) and global peak strain (GPS) in the three directions compared with the MIOCA group. The GPS in three directions were inversely associated with increased N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels, a greater LV infarct extent, and decreased LVEF in patients with AMI. NT-proBNP level was shown to be an independent determinant of the global longitudinal peak strain (GLPS) in patients with MINOCA and GPS in three directions in patients with MIOCA. Infarct size was an independent determinant of GPS in three directions in the MINOCA and MIOCA groups. MINOCA had a specific etiology, and patients with MINOCA had better myocardial function than those with MIOCA. Strain, infarct size on CMR imaging, and NT-proBNP level are reliable for monitoring cardiac dysfunction in patients with MINOCA. GLPS and global circumferential peak strain are useful early biomarkers of subclinical impairment in MINOCA.
- 1 January 2026
- Published by AME Publishing Company in Quantitative Imaging in Medicine and Surgery
- Vol. 16 (1) , 49
Open AccessClinical and cardiac magnetic resonance imaging features for differentiation between acute myocardial infarction with and without obstructive coronary arteries
Misdiagnosis often occurs in patients with myocardial infarction (MI) with nonobstructive coronary arteries (MINOCA) and MI with obstructive coronary arteries (MIOCA). This study explored the clinical and imaging characteristics of patients with MINOCA and MIOCA. Patients with acute MI (AMI) who underwent cardiac magnetic resonance (CMR) imaging and coronary angiography (CAG) were evaluated. According to coronary stenosis degree (>50%), patients with AMI (n=147) were divided into the MINOCA and MIOCA groups. The cardiac function and CMR characteristics of the two subgroups were emphasized in analysis. The MINOCA group had a lower proportion of patients with hypertension (29.4% vs. 55.2%), hyperlipoproteinemia (9.8% vs. 16.7%), diabetes (19.6% vs. 37.5%), wall motion abnormalities (39.3% vs. 75%), complex (both epicardial and subendocardial infarction) infarct type (19.6% vs. 29.2%), and multiple infarct territories (58.8% vs. 77.1%) than did the MIOCA group. Compared with the MIOCA group, the MINOCA group had a smaller left ventricular (LV) infarct size and a lower infarct size rate. The MINOCA group had a higher LV ejection fraction (LVEF) and global peak strain (GPS) in the three directions compared with the MIOCA group. The GPS in three directions were inversely associated with increased N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels, a greater LV infarct extent, and decreased LVEF in patients with AMI. NT-proBNP level was shown to be an independent determinant of the global longitudinal peak strain (GLPS) in patients with MINOCA and GPS in three directions in patients with MIOCA. Infarct size was an independent determinant of GPS in three directions in the MINOCA and MIOCA groups. MINOCA had a specific etiology, and patients with MINOCA had better myocardial function than those with MIOCA. Strain, infarct size on CMR imaging, and NT-proBNP level are reliable for monitoring cardiac dysfunction in patients with MINOCA. GLPS and global circumferential peak strain are useful early biomarkers of subclinical impairment in MINOCA.
- Open Access
- 10 December 2025
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 25 (1)
Effects of metabolic syndrome and its components on myocardial microcirculation in obstructive coronary artery disease patients: a CMR perfusion study
The study aimed to investigate the effects of metabolic syndrome (MetS) and its components on myocardial microcirculation perfusion in global and assigned
- 10 December 2025
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 25 (1)
Open AccessEffects of metabolic syndrome and its components on myocardial microcirculation in obstructive coronary artery disease patients: a CMR perfusion study
The study aimed to investigate the effects of metabolic syndrome (MetS) and its components on myocardial microcirculation perfusion in global and assigned
- 4 September 2025
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
- Vol. 27 (4) , 936
Immunoglobulin G4-related coronary arteritis
- 4 September 2025
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
- Vol. 27 (4) , 936
Immunoglobulin G4-related coronary arteritis
- Open Access
- 22 February 2025
- Published by Springer Nature in Pediatric Radiology
- Vol. 55 (5) , 1034
Type IIA pulmonary artery sling with tracheobronchial anomalies
- 22 February 2025
- Published by Springer Nature in Pediatric Radiology
- Vol. 55 (5) , 1034
Open AccessType IIA pulmonary artery sling with tracheobronchial anomalies
- 11 November 2024
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
- Vol. 26 (2) , 376
Type I coronary artery ectasia with a giant aneurysm
Yu-Shan Zhang, Zhi-Gang Yang, Ke Shi; Type I coronary artery ectasia with a giant aneurysm, European Heart Journal - Cardiovascular Imaging, , jeae294, htt
- 11 November 2024
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
- Vol. 26 (2) , 376
Type I coronary artery ectasia with a giant aneurysm
Yu-Shan Zhang, Zhi-Gang Yang, Ke Shi; Type I coronary artery ectasia with a giant aneurysm, European Heart Journal - Cardiovascular Imaging, , jeae294, htt
- 1 November 2024
- Published by Springer Nature in Pediatric Radiology
- Vol. 54 (13) , 2267-2268
Right coronary artery-to-right atrium fistula with multiple aneurysms
- 1 November 2024
- Published by Springer Nature in Pediatric Radiology
- Vol. 54 (13) , 2267-2268
Right coronary artery-to-right atrium fistula with multiple aneurysms
- Open Access
- 4 August 2023
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 22 (1) , 1-10
Association of insulin use with LV remodeling and clinical outcomes in diabetic patients with heart failure and reduced ejection fraction: assessed by cardiac MRI
Background: Insulin is commonly used in type 2 diabetes mellitus (T2DM) to achieve glycemic control. However, recent evidence showed that insulin use is associated with poor outcomes in the context of heart failure (HF). Since heart failure with reduced ejection fraction (HFrEF) accounts for approximately 50% of cases in the general HF population, we aimed to evaluate the effect of insulin treatment on left ventricular (LV) remodeling and contractility abnormalities in a HFrEF cohort and assess whether insulin was a predictor of adverse outcomes in this entity. Methods: A total of 377 HFrEF patients who underwent cardiac MRI were included and divided according to diabetes status and the need for insulin treatment. LV structural and functional indices, as well as systolic strains, were measured. The determinants of impaired myocardial strains were assessed using linear regression analysis. The associated endpoints were determined using a multivariable Cox proportional hazards model. Results: T2DM patients on insulin displayed a higher indexed LV end-diastolic volume and LV mass than those with T2DM not on insulin or those without T2DM, despite similar LV ejection fractions, accompanied by a higher three-dimensional spherical index (P < 0.01). Worse longitudinal and circumferential peak systolic strain was shown to occur in T2DM patients on insulin (P < 0.01). Insulin treatment was independently associated with impaired magnitudes of systolic strain. The median follow-up duration was 32.4 months (IQR, 15.6–43.2 months). Insulin treatment remained consistently associated with poor outcomes after adjustment for established confounders, with an adjusted hazard ratio of 3.11; (95% CI, 1.45–6.87; P = 0.009) in the overall cohort and 2.16 (95% CI, 1.08–4.59; P = 0.030) in the diabetes cohort. Conclusions: Insulin may further lead to adverse LV remodeling and contractile dysfunction in the context of HFrEF with T2DM. Considerable care should be taken when treating HFrEF patients with insulin.
- 4 August 2023
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 22 (1) , 1-10
Open AccessAssociation of insulin use with LV remodeling and clinical outcomes in diabetic patients with heart failure and reduced ejection fraction: assessed by cardiac MRI
Background: Insulin is commonly used in type 2 diabetes mellitus (T2DM) to achieve glycemic control. However, recent evidence showed that insulin use is associated with poor outcomes in the context of heart failure (HF). Since heart failure with reduced ejection fraction (HFrEF) accounts for approximately 50% of cases in the general HF population, we aimed to evaluate the effect of insulin treatment on left ventricular (LV) remodeling and contractility abnormalities in a HFrEF cohort and assess whether insulin was a predictor of adverse outcomes in this entity. Methods: A total of 377 HFrEF patients who underwent cardiac MRI were included and divided according to diabetes status and the need for insulin treatment. LV structural and functional indices, as well as systolic strains, were measured. The determinants of impaired myocardial strains were assessed using linear regression analysis. The associated endpoints were determined using a multivariable Cox proportional hazards model. Results: T2DM patients on insulin displayed a higher indexed LV end-diastolic volume and LV mass than those with T2DM not on insulin or those without T2DM, despite similar LV ejection fractions, accompanied by a higher three-dimensional spherical index (P < 0.01). Worse longitudinal and circumferential peak systolic strain was shown to occur in T2DM patients on insulin (P < 0.01). Insulin treatment was independently associated with impaired magnitudes of systolic strain. The median follow-up duration was 32.4 months (IQR, 15.6–43.2 months). Insulin treatment remained consistently associated with poor outcomes after adjustment for established confounders, with an adjusted hazard ratio of 3.11; (95% CI, 1.45–6.87; P = 0.009) in the overall cohort and 2.16 (95% CI, 1.08–4.59; P = 0.030) in the diabetes cohort. Conclusions: Insulin may further lead to adverse LV remodeling and contractile dysfunction in the context of HFrEF with T2DM. Considerable care should be taken when treating HFrEF patients with insulin.